About this trial
This prospective observational cohort study aims to evaluate the predictive performance of the Pediatric Sequential Organ Failure Assessment (pSOFA) score for mortality and selected clinical outcomes among critically ill children admitted to the Pediatric Intensive Care Unit (PICU). A total of 100 children will be enrolled and followed during their PICU stay.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 1 month to 18 years.
PICU admission requiring intensive monitoring and/or organ support.
Availability of required pSOFA clinical and laboratory data.
Written informed consent from parent/legal guardian.
Disqualifiers
Age less than 1 month.
PICU stay less than 24 hours.
Incomplete data required for pSOFA calculation.
Readmission during the same hospitalization.
Trial population
Critically ill children aged 1 month to 18 years admitted to the Pediatric Intensive Care Unit (PICU) of Assiut University Children's Hospital who fulfill the eligibility criteria.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
In-Hospital Mortality
Proportion of critically ill children who die during hospital stay, assessed by review of medical records and PICU follow-up.
Secondary outcomes
PICU Length of Stay
Mean number of days spent in the Pediatric Intensive Care Unit (PICU), assessed by review of medical records.
Duration of Mechanical Ventilation
Mean number of days of mechanical ventilation, assessed by review of medical records.
Need for Vasoactive Support
Proportion of children requiring vasoactive medications during PICU stay, assessed by review of medical records.
Multiple Organ Dysfunction Syndrome (MODS)
Proportion of children who develop multiple organ dysfunction syndrome (MODS) during PICU stay, assessed by review of medical records.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: